FI67222B - Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa - Google Patents

Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa Download PDF

Info

Publication number
FI67222B
FI67222B FI802590A FI802590A FI67222B FI 67222 B FI67222 B FI 67222B FI 802590 A FI802590 A FI 802590A FI 802590 A FI802590 A FI 802590A FI 67222 B FI67222 B FI 67222B
Authority
FI
Finland
Prior art keywords
clavulanic acid
tert
acetone
butylamine
klavulansyra
Prior art date
Application number
FI802590A
Other languages
English (en)
Finnish (fi)
Other versions
FI67222C (fi
FI802590A (fi
Inventor
Michael Allen Cook
Alan David Curzons
Robert Bennett Wilkins
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10507413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI67222(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of FI802590A publication Critical patent/FI802590A/fi
Publication of FI67222B publication Critical patent/FI67222B/fi
Application granted granted Critical
Publication of FI67222C publication Critical patent/FI67222C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (12)

1. Förfarande för rening av klavulansyra eller ett farma-ceutiskt acceptabelt sait därav, kännetecknat av att man: i) bringar oren klavulansyra i kontakt med tert.-butylamin i ett organiskt lösningsmedel, ii) isolerar tert.-butylaminsaltet av klavulansyra, och iii) omvandlar det sälunda bildade tert.-butylaminsaltet tili klavulansyra eller ett farmaceutiskt acceptabelt sait därav.
2. Förfarande enligt patentkravet 1, kännetecknat av att den bildade klavulansyran föreligger i form av dess farmaceutiskt acceptabla alkali- eller jordalkalimetallsalt.
3. Förfarande enligt patentkravet 2, kännetecknat av att den bildade klavulansyran föreligger i form av dess natrium-eller kaliumsalt.
4. Förfarande enligt nägot av patenkraven 1-3, kännetecknat av att man som organiskt lösningsmedel använder etylacetat, metylacetat, propylacetat, n-butylacetat, metyl-etylketon, aceton, metylisobutylketon, tetrahydrofuran eller blandningar av sädana lösningsmedel.
5. Förfarande enligt patentkravet 4, kännetecknat av att man som lösningsmedel använder etylacetat.
6. Användning av tert.-butylaminsaltet av klavulansyra som mellanprodukt vid framställning av klavulansyra eller ett farmaceutiskt acceptabelt sait därav.
7. Mellanprodukt för framställning av klavulansyra eller ett farmaceutiskt acceptabelt sait därav, kännetecknad av att den utgörs av acetonsolvatet av tert-butylaminsaltet av klavulansyra.
FI802590A 1979-08-24 1980-08-18 Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa FI67222C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7929544 1979-08-24
GB7929544 1979-08-24

Publications (3)

Publication Number Publication Date
FI802590A FI802590A (fi) 1981-02-25
FI67222B true FI67222B (fi) 1984-10-31
FI67222C FI67222C (fi) 1985-02-11

Family

ID=10507413

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802590A FI67222C (fi) 1979-08-24 1980-08-18 Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa

Country Status (20)

Country Link
US (1) US4647659A (sv)
EP (1) EP0026044B1 (sv)
JP (2) JPS5634685A (sv)
KR (1) KR860000343B1 (sv)
AU (1) AU535198B2 (sv)
CA (1) CA1157862A (sv)
DE (1) DE3063683D1 (sv)
DK (1) DK156069C (sv)
ES (1) ES494431A0 (sv)
FI (1) FI67222C (sv)
GR (1) GR69870B (sv)
HK (1) HK1086A (sv)
HU (1) HU185619B (sv)
IE (1) IE50047B1 (sv)
IL (1) IL60885A (sv)
MY (1) MY8500999A (sv)
NO (1) NO165241C (sv)
NZ (1) NZ194703A (sv)
PL (1) PL139811B1 (sv)
ZA (1) ZA805206B (sv)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326486C (en) * 1987-01-29 1994-01-25 Dennis Edward Clark Potassium clavulanate
ES2010143A6 (es) 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
JPH0457085U (sv) * 1990-09-14 1992-05-15
JPH0569557U (ja) * 1992-02-26 1993-09-21 東京電機工業株式會社 固体蓄熱装置
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
AT475U1 (de) * 1992-06-11 1995-11-27 Smithkline Beecham Plc Verfahren zur herstellung von clavulansaeure
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
AT1447U1 (de) * 1992-06-11 1997-05-26 Smithkline Beecham Plc Neue salze von clavulansäure
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
AT1446U1 (de) * 1992-10-31 1997-05-26 Smithkline Beecham Plc Verfahren zur herstellung und/oder reinigung von clavulansäure
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5760218A (en) * 1993-03-26 1998-06-02 Gist-Brocades N.V. Diamine salts of clavulanic acid
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
AU682030B2 (en) * 1993-03-26 1997-09-18 Dsm N.V. Diamine salts of clavulanic acid
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
EP0658558B1 (en) 1993-11-17 2001-01-24 Biochemie Gesellschaft M.B.H. Separation of cephalosporin isomers
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
GB9426261D0 (en) * 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
GB9500977D0 (en) 1995-01-19 1995-03-08 Smithkline Beecham Plc Novel process
AP9701116A0 (en) * 1995-02-25 1997-10-31 Spurcourt Ltd Clavulanic acid salts
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
JPH09152148A (ja) * 1995-09-29 1997-06-10 Tokyo Denki Kogyo Kk 蓄熱式空調装置
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
EP1097238A1 (en) * 1998-07-03 2001-05-09 Dsm N.V. Fermentation process to produce clavulanic acid at a low concentration of free amino acids
WO2000018947A1 (en) * 1998-09-29 2000-04-06 Dsm N.V. Fermentation of clavulanic acid at a controlled level of ammonia
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
ES2177391B1 (es) * 2000-04-19 2004-08-16 Felipe Lopez Oliva Muñoz Protesis de disco cervical.
CN1222528C (zh) * 2000-05-13 2005-10-12 史密斯克莱·比奇曼公司 提纯克拉布兰酸盐的方法
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法
CN108822134B (zh) * 2018-04-25 2021-06-25 国药集团威奇达药业有限公司 克拉维酸叔丁胺盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
SE421796B (sv) * 1975-02-07 1982-02-01 Glaxo Lab Ltd Forfarande for rening av klavulansyra och dess salter
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB1572912A (en) * 1977-01-19 1980-08-06 Beecham Group Ltd Clavulanic acid esters
US4255332A (en) * 1977-09-01 1981-03-10 Beecham Group Limited Process for the preparation of potassium clavulanate from lithium clavulanate

Also Published As

Publication number Publication date
KR830003492A (ko) 1983-06-20
MY8500999A (en) 1985-12-31
IL60885A0 (en) 1980-10-26
AU535198B2 (en) 1984-03-08
ES8106157A1 (es) 1981-07-16
DE3063683D1 (en) 1983-07-14
JPH0415234B2 (sv) 1992-03-17
ZA805206B (en) 1981-08-26
DK363080A (da) 1981-02-25
GR69870B (sv) 1982-07-20
CA1157862A (en) 1983-11-29
IE801777L (en) 1981-02-24
EP0026044A1 (en) 1981-04-01
JPH02167286A (ja) 1990-06-27
IL60885A (en) 1983-11-30
US4647659A (en) 1987-03-03
NO802498L (no) 1981-02-25
JPH0234954B2 (sv) 1990-08-07
FI67222C (fi) 1985-02-11
IE50047B1 (en) 1986-02-05
NO165241C (no) 1991-01-16
FI802590A (fi) 1981-02-25
KR860000343B1 (ko) 1986-04-12
EP0026044B1 (en) 1983-06-08
HU185619B (en) 1985-03-28
PL139811B1 (en) 1987-02-28
DK156069B (da) 1989-06-19
DK156069C (da) 1989-12-04
NO165241B (no) 1990-10-08
ES494431A0 (es) 1981-07-16
JPS5634685A (en) 1981-04-06
AU6163280A (en) 1981-04-09
NZ194703A (en) 1983-09-02
HK1086A (en) 1986-01-10
PL226397A1 (sv) 1981-05-22

Similar Documents

Publication Publication Date Title
FI67222B (fi) Foerfarande foer rening av klavulansyra och saosom mellanprodukt anvaendbara aminsalt av klavulansyra samt foerfarande foer framstaellning av dessa
FI96952C (sv) Förfarande för rengöring av klavulansyra med hjälp av vissa polyaminer
CA1103264A (en) Purification of pseudomonic acid
KR100200242B1 (ko) 클라불란산염의 제조 방법
US4454069A (en) Clavulanic acid salts and their preparation from the tertiary butyl amine salt
FI101965B (sv) Användning av 2-amino-2,4,4-trimetylpentansalt av klavulansyra vid fra mställning av alkali- eller alkaliskt jordartsmetallsalt av klavulansy ra
US5726170A (en) Clavulanic acid salts
AU2006215708A1 (en) Purification of mupirocin
KR100827898B1 (ko) 클라불란산의 염의 정제 방법
EP0941229B1 (en) Purification of fermented clavulanic acid
PL188634B1 (pl) Sposób wytwarzania potasowej soli kwasu klawulanowego
PL172021B1 (pl) Sposób oczyszczania kwasu klawulanowego PL
US20010029038A1 (en) Purification of fermented clavulanic acid
DK157555B (da) Clavulansyresalt i form af et acetonesolvat og fremgangsmaade til fremstilling deraf.
CS238941B1 (cs) Způsob čištění 2-m@rkapto-5-methyi-13,4-thiadiazo!u

Legal Events

Date Code Title Description
MA Patent expired

Owner name: BEECHAM GROUP LIMITED